MedTrace Logo

Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression

NCT07676851 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-06-30

No results posted yet for this study

Summary

The goal of this observational study is to learn about the ability of a point risk score prediction model, developed using electronic medical record data, to predict the risk of progression from geriatric depression to dementia in older Chinese adults. The main questions it aims to answer are:

Does a higher point risk score increase the risk of developing dementia in older adults with depression?

What is the accuracy of the point risk score prediction model in identifying individuals at high risk of dementia among older adults with depression?

Participants will receive their usual medical care as they normally would. No new treatments, tests, or procedures will be performed specifically for this study. The research team will collect data from their electronic medical records, including depression diagnoses, dementia diagnoses, comorbidities, medication records, and follow-up information. The point risk score will be calculated based on these routinely collected clinical data.

Conditions

  • Alzheimer Dementia (AD)
  • Dementia
  • Late Life Depression (LLD)
  • Risk Scores
  • Prediction
  • Chinese Population
  • Obs e r
  • Observational Cohort Study
  • External Validation

Interventions

OTHER

No Intervention: Observational Cohort

This is an observational study with no study-specific intervention. All participants receive their routine standard medical care as usual. No new drugs, devices, procedures, or behavioral modifications are assigned as part of this research.

Sponsors & Collaborators

  • Second Affiliated Hospital of Nanchang University

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-01
Primary Completion
2030-06-01
Completion
2030-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07676851 on ClinicalTrials.gov